651 results Les dernières actualités juridiques directement dans votre boîte e-mail Vous souhaitez recevoir rapidement les informations concernant les derniers développements dans les domaines qui vous intéressent? Nous vous invitons à vous inscrire à nos Legal Updates. The Stibbe Annual Competition Update will take place on 24 January 2023 2023 will be the end game of the European Commission’s competition policy review. Shiny new competition policy tools for dealing with social, digital and vertical aspects as well as foreign investment issues are upcoming, ongoing or being finalised. FSR zorgt voor nieuwe uitdagingen bij transacties en aanbestedingen Op 12 januari van dit jaar trad de Foreign Subsidies Regulation (FSR) in werking, die per 12 oktober een meldplicht bij de Europese Commissie voor bepaalde transacties en aanbestedingen introduceert. Dutch national security screening regime enters into force The Dutch national security screening regime (Wet veiligheidstoets investeringen, fusies en overnames or Wet Vifo) enters into force today, 1 June. Levelling the playing field in 2023: new tools and hurdles While 2022 revolved around new and improved regulatory tools, the focus in 2023 will be on putting these tools to use. More merger-related obligations, digital sector scrutiny and clarity on competition-law and consumer-law aspects is imminent. C'est le ton qui fait la musique – The end of employer copyrights? The CJEU decision in the National Orchestra of Belgium decision shakes up employer copyright in the Netherlands. With new consent and compensation requirements, are your employment contracts still airtight? Discover the implications of the decision here. The long and (un)winding road of ‘killer acquisition’ Illumina/Grail Crystal ball gazing into prospective innovation rat races when assessing vertical mergers may soon be all in a day’s work for the European Commission. Innovation was a recurring theme in the Commission’s handling of the Illumina/Grail deal. If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug. The ECJ’s ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines. Commission steers market definition to the 21st century Companies have a new and improved tool for the competitive assessment of their conduct and intended acquisitions. The European Commission has updated its guidance on how to define relevant markets for the purpose of EU competition law enforcement. Stibbe advises A-Lanes consortium on A15 PPP refinancing and dispute Stibbe advised several matters including the A-Lanes A15 Mobility consortium on the refinancing of the A15 Maasvlakte-Vaanplein PPP project. Stibbe advises on A24 Blankenburg DBFM/PPP project Stibbe advised the lenders, consisting of a mix of bank lenders and the EIB, in the largest PFI transaction in recent years, providing finance to BAAK Blankenburg-Verbinding B.V. Stibbe advises VEENIX consortium Stibbe has advised the VEENIX consortium on on the tender, contracting and reaching financial close in the PPP Project A9 Badhoevedorp-Holendrecht in 2019. Stibbe advises consortium on restructuring of Afsluitdijk PPP project Stibbe advises the consortium consisting of Van Oord, BAM and Rebel group in relation to the restructuring of the newly reinforced Afsluitdijk PPP Project (DBFM). Tom Verdonk Associate Amsterdam Ali al Khatib Senior Associate Amsterdam Fanny Parmentier Junior Associate Brussels Noor Dewulf Junior Associate Brussels Pagination Previous page Page 28 Current page 29 Page 30 Page 31 Next page
Les dernières actualités juridiques directement dans votre boîte e-mail Vous souhaitez recevoir rapidement les informations concernant les derniers développements dans les domaines qui vous intéressent? Nous vous invitons à vous inscrire à nos Legal Updates.
The Stibbe Annual Competition Update will take place on 24 January 2023 2023 will be the end game of the European Commission’s competition policy review. Shiny new competition policy tools for dealing with social, digital and vertical aspects as well as foreign investment issues are upcoming, ongoing or being finalised.
FSR zorgt voor nieuwe uitdagingen bij transacties en aanbestedingen Op 12 januari van dit jaar trad de Foreign Subsidies Regulation (FSR) in werking, die per 12 oktober een meldplicht bij de Europese Commissie voor bepaalde transacties en aanbestedingen introduceert.
Dutch national security screening regime enters into force The Dutch national security screening regime (Wet veiligheidstoets investeringen, fusies en overnames or Wet Vifo) enters into force today, 1 June.
Levelling the playing field in 2023: new tools and hurdles While 2022 revolved around new and improved regulatory tools, the focus in 2023 will be on putting these tools to use. More merger-related obligations, digital sector scrutiny and clarity on competition-law and consumer-law aspects is imminent.
C'est le ton qui fait la musique – The end of employer copyrights? The CJEU decision in the National Orchestra of Belgium decision shakes up employer copyright in the Netherlands. With new consent and compensation requirements, are your employment contracts still airtight? Discover the implications of the decision here.
The long and (un)winding road of ‘killer acquisition’ Illumina/Grail Crystal ball gazing into prospective innovation rat races when assessing vertical mergers may soon be all in a day’s work for the European Commission. Innovation was a recurring theme in the Commission’s handling of the Illumina/Grail deal.
If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug.
The ECJ’s ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines.
Commission steers market definition to the 21st century Companies have a new and improved tool for the competitive assessment of their conduct and intended acquisitions. The European Commission has updated its guidance on how to define relevant markets for the purpose of EU competition law enforcement.
Stibbe advises A-Lanes consortium on A15 PPP refinancing and dispute Stibbe advised several matters including the A-Lanes A15 Mobility consortium on the refinancing of the A15 Maasvlakte-Vaanplein PPP project.
Stibbe advises on A24 Blankenburg DBFM/PPP project Stibbe advised the lenders, consisting of a mix of bank lenders and the EIB, in the largest PFI transaction in recent years, providing finance to BAAK Blankenburg-Verbinding B.V.
Stibbe advises VEENIX consortium Stibbe has advised the VEENIX consortium on on the tender, contracting and reaching financial close in the PPP Project A9 Badhoevedorp-Holendrecht in 2019.
Stibbe advises consortium on restructuring of Afsluitdijk PPP project Stibbe advises the consortium consisting of Van Oord, BAM and Rebel group in relation to the restructuring of the newly reinforced Afsluitdijk PPP Project (DBFM).